Idamycin Pfs Solution For Injection 1Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Idamycin PFS: Solution for injection (1mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

IDARUBICIN (eye da RUE bi sin) is a chemotherapy drug. This medicine is used to treat acute myeloid leukemia (AML).

In-Depth Information
Select a Medication

Idamycin PFS 5mg/5ml Solution for Injection

NDC: 000132200
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Acute Myelogenous Leukemia (AML), Acute Promyelocytic Leukemia (APL)

Sometimes used for but not FDA approved for the following conditions:
Non-Hodgkin's Lymphoma (NHL), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia (CML)

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Store in original container
Idamycin PFS 5mg/5ml Solution for Injection

Reported Side Effects for Idamycin PFS 5mg/5ml Solution for Injection

Skin Rash Incidence:
<46.0%*
Severity: MILD
Onset: EARLY
Mouth Sores Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
<16.0%*
Severity: MODERATE
Onset: EARLY
Blistery Rash Incidence:
<46.0%*
Severity: MODERATE
Onset: EARLY
Vomiting Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Heart Attack Incidence:
<16.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Beat Incidence:
<16.0%*
Severity: SEVERE
Onset: EARLY
Hives Incidence:
<46.0%*
Severity: MILD
Onset: RAPID
Convulsions Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Nerve Pain Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Pancytopenia Incidence:
>10.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
20.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
26.0%*
Severity: MILD
Onset: EARLY
Bleeding Incidence:
63.0%*
Severity: MODERATE
Onset: EARLY
Loose Stools Incidence:
73.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
73.0%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
77.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
95.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Idamycin PFS

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5